Arixtra (Fondaparinux) for Lupus

Overview
Arixtra is a prescription medication approved by the Food and Drug Administration (FDA) to treat acute deep vein thrombosis (DVT) in conjunction with Warfarin, and to prevent DVT during surgery. Arixtra may also be referred to by its drug name, Fondaparinux.

Arixtra is an anticoagulant, or blood thinner. Arixtra is believed to work by inactivating some aspects of the body’s blood clotting process.

How do I take it?
Prescribing information states that Arixtra is administered as a subcutaneous injection.

Arixtra comes in prefilled syringe form.

Side effects
The FDA-approved label for Arixtra lists common side effects including dizziness, insomnia, nausea, vomiting, rash, and injection site reactions.

Rare but serious side effects listed for Arixtra include hemorrhage and spinal or epidural hematomas that can result in permanent paralysis.

For more details about this treatment, visit:

Arixtra – RxList